15 Apr 2025 13:00 CEST

Issuer

Vistin Pharma ASA

Oslo, Norway, 15 April 2025

Vistin Pharma ASA (VISTN) will release its first quarter results on Friday 25th
of April 2025. Vistin Pharma will host a conference call for all shareholders
and interested parties at the same day at 08:30 CET. There will be a Q&A session
following the management discussion.

The conference call will be held in English.

The first quarter conference call will be available via web and audio through
the following access points:

Webcast: https://edge.media-server.com/mmc/p/9g56ohth
(https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fedge.media-
server.com%2Fmmc%2Fp%2F9g56ohth&data=05%7C02%7CAlexander.Karlsen%40vistin.com%7C
cd63feffa5b24af9d8ce08dd6ba9d720%7C2fcdf060b2c2456e8bb7944b7e40981a%7C0%7C0%7C63
8785100003206993%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDA
wMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=TZ%2B5l
QKr0hsPrLA8vXsxn3ytEE3Vd4vC1WFcutlpoyY%3D&reserved=0)

Telephone conference (online registration):

https://register-conf.media-
server.com/register/BI532205913f1d42059d747081a631bec9
(https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fregister-
conf.media-
server.com%2Fregister%2FBI532205913f1d42059d747081a631bec9&data=05%7C02%7CAlexan
der.Karlsen%40vistin.com%7Ccd63feffa5b24af9d8ce08dd6ba9d720%7C2fcdf060b2c2456e8b
b7944b7e40981a%7C0%7C0%7C638785100003222025%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1h
cGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D
%7C0%7C%7C%7C&sdata=MveoY6gaqdl8b6Z3lvdjCC7vejoFmXNoKIvyTnxcA%2FI%3D&reserved=0)

*****

For further information, please contact:

Alexander Karlsen
CFO
+47 97053621
alexander.karlsen@vistin.com

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin
Hydrochloride (API). The Metformin is also available as Direct Compressible
lubricated granules. As a solely dedicated European Metformin producer, Vistin
Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin
Pharma is headquartered in Oslo, Norway, and has highly qualified employees and
a dedicated manufacturing facility in Kragerø.


Source

Vistin Pharma ASA

Provider

Oslo Børs Newspoint

Company Name

VISTIN PHARMA

ISIN

NO0010734122

Symbol

VISTN

Market

Euronext Oslo Børs